Amalgamated Bank’s Akoya BioSciences AKYA Stock Holding History

Amalgamated Bank’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-465	Closed	-$1K	–	3015
2025 Q1	$1K	Hold	465	–	–	﹤0.01%	2896
2024 Q4	$1K	Hold	465	–	–	﹤0.01%	2937
2024 Q3	$1K	Hold	465	–	–	﹤0.01%	2958
2024 Q2	$1K	Hold	465	–	–	﹤0.01%	2975
2024 Q1	$2K	Sell	465 -1,962	-81%	-$10.2K	﹤0.01%	2866
2023 Q4	$12K	Sell	2,427 -138	-5%	-$573	﹤0.01%	2825
2023 Q3	$12K	Hold	2,565	–	–	﹤0.01%	2850
2023 Q2	$19K	Buy	2,565 +472	+23%	+$3.15K	﹤0.01%	2757
2023 Q1	$17K	Sell	2,093 -331	-14%	-$3.46K	﹤0.01%	2686
2022 Q4	$23K	Hold	2,424	–	–	﹤0.01%	2709
2022 Q3	$28K	Buy	2,424 +38	+2%	+$501	﹤0.01%	2704
2022 Q2	$31K	Buy	2,386 +197	+9%	+$2.04K	﹤0.01%	2699
2022 Q1	$24K	Buy	+2,189	New	+$25.4K	﹤0.01%	2740

Other funds holding AKYA

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCA

Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Amalgamated Bank's AKYA Position: Q2 2025 in Review

Amalgamated Bank sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 465 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in AKYA in Q1 2022 and held it in 13 quarters. The position peaked at $31K in Q2 2022. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

Amalgamated Bank reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 465 Akoya BioSciences shares in Q2 2025, an estimated $1K.
Amalgamated Bank first reported a position in Akoya BioSciences in Q1 2022 and held it in 13 quarters.
Amalgamated Bank's Akoya BioSciences position peaked at $31K in Q2 2022.
58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.